MOUNT LAUREL, N.J., Dec. 20 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ) is pleased to announce that its SpeechQ for Radiology(TM) product was again rated number one for front-end speech recognition by customers, according to KLAS Enterprises' "Top 20: 2006 Best in KLAS Awards" Report.(1) The SpeechQ for Radiology solution first qualified for a KLAS review in early 2006 and was subsequently ranked as the number one solution in front-end speech recognition in the KLAS Enterprises Speech Recognition Report published on April 28, 2006.
"It's very gratifying to know that SpeechQ for Radiology continues to be highly valued by our customers," says Scott Bennett, MedQuist's senior vice president of Sales and Marketing. "We have experienced a lot of success with our speech recognition solutions over the past 18 months. Many of our customers have used other speech recognition products and tell us that our solutions provide them with superior workflow and accuracy, which allows them to be more productive."
KLAS regularly surveys and interviews more than 4,500 hospitals to develop an extensive database of various healthcare vendors' products and services, including information on vendor installation and post-live support, as well as success indicators and business indicators.
SpeechQ, which is powered by an embedded Philips SpeechMagic(TM) engine, allows physicians to easily become proficient with speech recognition technology within a few hours of use. Dr. William Keyes, a neuroradiologist at Inland Imaging, LLC in Spokane, Washington, who often interprets radiology exams for emergency room patients, observes, "It is not unusual for my final report to be printing in the ED before the patient has even been transported back to the department. Before implementing SpeechQ for Radiology, I would have to relay my preliminary findings verbally by telephone or by a handwritten fax." He adds, "My reports are more accurate since I am able to create a final report while my patients' images are displayed, and I now have more time for actually viewing the images."
About MedQuist
MedQuist, a member of the Philips Group of Companies, is a leading provider of clinical documentation workflow solutions in support of the electronic health record. MedQuist provides electronic medical transcription, health information and document management products and services, including digital dictation, speech recognition, Web-based transcription, electronic signature, medical coding, mobile dictation devices, and outsourcing services.
About KLAS
KLAS began to measure and report Healthcare Information Technology (HIT) vendor performance in 1996. To candidly gather performance ratings, KLAS confidentially interviews thousands of professionals in healthcare annually. The result of the interviews is an extensive HIT performance database representing over 4,500 healthcare facilities and 500 products. Vendors, consultants, investment bankers and healthcare providers use KLAS performance reports. For more information, contact KLAS Enterprises, LLC at 800-920-4109 or visit the KLAS web site at http://www.healthcomputing.com/.
"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such risks and uncertainties, which could cause actual results to differ from those contained in forward-looking statements include, but are not limited to: (1) our ability to recruit and retain qualified transcriptionists and other employees; (2) the impact of new services or products on the demand for our existing services; (3) our current dependence on medical transcription for substantially all of our business; (4) our ability to expand our customer base; (5) changes in law, including, without limitation, the impact the Health Insurance Portability and Accountability Act (HIPAA) will have on our business; (6) infringement on the proprietary rights of others; (7) risks inherent in diversifying into other businesses; (8) any continuation of pricing pressures and declining billing rates; (9) difficulties relating to the implementation of management changes throughout the Company; (10) the outcome of pending and future legal and regulatory proceedings and investigations; and (11) any direct or indirect impact of the matters disclosed in the Form 8-K filed by the Company on November 9, 2006. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.
(1) (C) Copyright 2006 KLAS Enterprises. All rights reserved.
